Novartis AG Sells 70.68% Stake in Novartis India to ChrysCapital; NIL Plans Tier 2-3 Push
Novartis AG will transfer its 70.68% stake in NIL to ChrysCapital, with closing expected in Q3 2026. NIL plans therapy-aligned acquisitions and deeper Tier 2-3 reach across five anchor therapy areas.